Richard J. Napolitano - Feb 1, 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Feb 1, 2023
Transactions value $
-$25,973
Form type
4
Date filed
2/3/2023, 03:09 PM
Previous filing
Sep 26, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +2.02K +128.11% 3.6K Feb 1, 2023 Direct F1
transaction TDOC Common Stock Sale -$26K -787 -21.89% $33.00 2.81K Feb 2, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -2.02K -49.99% $0.00 2.02K Feb 1, 2023 Common Stock 2.02K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3 On February 1, 2021, the reporting person was granted 6,058 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.